genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Artificial Intelligence
AstraZeneca, DeepMatter Launch AI-Based Compound Synthesis Collaboration
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Financing
Benchtop Genome Engineering Platform Developer Inscripta Raises $125M in Series D…
News
Human Genes 10% More Numerous, If You Count smORFs
News
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen…
Insights
Bioprocessing
Vaccine Production in Modular Systems
Bioprocessing
Looking Towards the Digital Lab: An Interview with Tetrascience’s CEO
Bioprocessing
Getting at Glycosylation
Bioprocessing
Insect Pupae May Transform Protein Production
Bioprocessing
Optimizing Biotherapeutic Onboarding
A-Lists
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Bioprocessing
Vaccine Production in Modular Systems
Bioprocessing
Looking Towards the Digital Lab: An Interview with Tetrascience’s CEO
Bioprocessing
Getting at Glycosylation
News
Antibiotic Resistance Mechanism Shows Achilles’ Heel
Magazine
All
Supplement
December 2019 Vol. 39 No. 12
CRISPR Vehicles Break Down Barriers to In Vivo Genome Editing
December 2019 Vol. 39 No. 12
For Whom the Perturbed Cell Signaling Pathway Tolls
December 2019 Vol. 39 No. 12
Metabolomics Technology Navigates Oceans of Data
December 2019 Vol. 39 No. 12
Taking Cell Lines to the Bank
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Dynamic Microbiome
December 2019 Vol. 39 No. 12
Understanding and Overcoming the Immune Response from Synthetic mRNAs
December 2019 Vol. 39 No. 12
Accelerating AAV to the Clinic with Purification Improvements
December 2019 Vol. 39 No. 12
Evaluation of a Small-Scale Perfusion Mimic for Intensified Processes
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Drug Discovery
High-Content Analysis
High-Content Analysis
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
High-Content Analysis
Bayer Taps ChromoTek’s Drug Profiling Technology
High-Content Analysis
Plexpress to Raise up to $2.3M to Commercialize Multiplex Gene-Expression Analysis Platform
High-Content Analysis
Leica Microsystems and Definiens Ink Co-Marketing Agreement for Imaging and High-Content Analysis Products
High-Content Analysis
ADME Services Firm Cyprotex Buys Apredica for £2.68M to Enter Toxicology Market
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Acquired company comes with Cellumen’s Cellular Systems Biology IP and assets. [© Alexander Raths - Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug6_2010_7868578_WomanWithLabware_CyprotexBuysApredica7753313689-265x198.jpg "ADME Services Firm Cyprotex Buys Apredica for £2.68M to Enter Toxicology Market")
